U.S. Wireless Telecom Stock News

AGNC Investment Corp. previously announced that its Board of Directors declared a US$0.12 per-share cash dividend for March 2026, payable on April 10, 2026 to common stockholders of record as of March 31, 2026. The simultaneous declaration of quarterly dividends across multiple preferred series, with varying fixed-to-floating and fixed reset structures, underscores AGNC’s emphasis on maintaining consistent income for both common and preferred shareholders. We’ll now examine how reaffirming...

GlobalFoundries (NasdaqGS:GFS) is expanding into silicon photonics, working with Flexcompute to link photonic device design tools directly to its manufacturing stack. The collaboration focuses on optical interconnects for AI data centers, aiming to streamline the path from simulation to fabrication. This move targets a growing market in data center optics while seeking to lower design and integration hurdles for customers. GLOBALFOUNDRIES, trading at $42.47, is drawing attention in advanced...

Considering whether Definium Therapeutics at around US$17.64 still offers value, or if most of the opportunity is already priced in. The stock has seen a 5.3% decline over the last 7 days, but sits on gains of 12.0% over 30 days, 29.3% year to date and 163.3% over 1 year, with a very large 3 year return that is more than 5x, although the 5 year return is a 54.3% decline. Recent market attention has been shaped by broader interest in high growth pharmaceutical and biotech names, where...

On March 12, 2026, analysts at Bernstein upgraded The Cigna Group to “Outperform,” citing the impact of PBM reform, an FTC settlement, and changes to the company’s pharmacy benefit model on investor perception. This shift in analyst stance highlights how regulatory outcomes and PBM model adjustments can influence expectations around Cigna’s health services business mix and risk profile. Next, we’ll explore how Bernstein’s upgrade, rooted in PBM reform and regulatory developments, may reshape...

Artisan Partners has taken a new small cap position in Bruker (NasdaqGS:BRKR), citing confidence in the company’s acquisitions and product pipeline. The investment thesis points to anticipated easing of short term market headwinds as a support for future profit growth. Bruker’s share price stands at $34.03 after a period of pressure, with the stock down 7.6% over the past week and 6.8% over the past month. The drawdown is more extended over longer periods, with a 29.3% decline year to date...

Earlier this month, Capricor Therapeutics reported Q4 2025 and full-year results showing a wider net loss of US$30.17 million for the quarter and US$105.04 million for the year, alongside continued investment in its Duchenne muscular dystrophy pipeline. A key development was new Phase 3 HOPE-3 data and the FDA’s decision to resume review of Deramiocel’s Biologics License Application, setting an August 22, 2026 action date for a potential decision on treating Duchenne cardiomyopathy. With the...

Why TTM Technologies (TTMI) Is On Investors’ Radar Today TTM Technologies (TTMI) is drawing attention after recent share price moves, with the stock showing varied short term returns and a stronger performance over the past year that may prompt closer portfolio review. See our latest analysis for TTM Technologies. The latest share price of $95.31 comes after a 42.06% 90 day share price return and a very large 1 year total shareholder return. Together, these indicate strong recent momentum...

Himax Technologies (NasdaqGS:HIMX) highlighted new AI powered modules and automotive display ICs at Embedded World 2026. The company showcased WiseEye, WiseGuard and PalmVein ultralow power AI solutions for smart home, security, automotive and drone uses. Rumors point to potential collaborations with major tech firms for smart glasses integration and AI data center applications. For you as an investor, this matters because Himax Technologies, long known for display driver ICs, is now...

If you are trying to figure out whether Ondas at around US$10.83 is still attractively priced, the starting point is understanding what that share price really implies about the business. The stock has shown sharp moves, with a 10.2% return over the last 7 days, 16.3% over 30 days, a small 1.7% decline year to date, and a very large gain over the past year and over the last 3 years. Recent coverage has focused on Ondas as a higher risk, higher return name within the tech space, which helps...

Event driven move in PPL stock PPL (PPL) is back in focus after the company reported 2025 results, issued a 2026 EPS growth forecast, extended its annual EPS growth target through at least 2029, and outlined a US$23b infrastructure investment plan. See our latest analysis for PPL. At a share price of US$38.05, PPL has had a 9.5% 90 day share price return and a 12.2% 1 year total shareholder return, suggesting momentum has been building alongside its latest results and infrastructure plan. If...

Wondering if Sanmina's share price really reflects its underlying value, or if the recent run in the stock has left mispricing on the table. The stock closed at US$125.03, with returns of 59.8% over 1 year and 118.1% over 3 years, even as the share price has seen a 14.3% drop over 30 days and a 21.5% fall year to date. Recent coverage has focused on Sanmina's role in technology manufacturing and its positioning within the broader electronics supply chain, giving investors more information to...

Crane NXT (NYSE:CXT) has appointed technology and manufacturing executive Jeffrey Benck to its Board of Directors. Longtime director James L.L. Tullis will step down from the board after the upcoming Annual Meeting. The board change introduces new industry experience and marks the end of a lengthy period of service by Tullis. For investors tracking Crane NXT, the board shift comes at a time when the share price stands at $41.37, with the stock showing a 21.6% decline over the past 30 days...

DHT Holdings, Inc. has already taken delivery of its second VLCC newbuilding, the DHT Addax, from Hanwha Ocean Co. Ltd., with the fully funded vessel now operating in the spot market as part of a four-ship program scheduled for completion in the first half of 2026. This incremental capacity, arriving in a short time frame and fully financed, directly enhances DHT’s service offering and potential earnings power without stretching the balance sheet. We’ll now examine how this fully funded VLCC...

In March 2026, Goosehead Insurance, Inc. filed a shelf registration for up to US$66.65 million, covering 1,510,000 common shares in an employee stock ownership plan (ESOP)-related offering. This ESOP-linked shelf registration highlights Goosehead’s emphasis on employee ownership, which can influence incentives, capital structure, and longer-term business alignment. We’ll now examine how this ESOP-related shelf registration could influence Goosehead Insurance’s investment narrative and its...

Main Street Capital recently completed a US$61.5 million portfolio investment to support the minority recapitalization of a specialized structural steel fabricator, combining first-lien senior secured term debt, a direct minority equity stake, and a revolving credit facility for future initiatives and working capital. Management also reported record return on equity and growth in net asset value for the latest quarter, underscoring how its blended debt-and-equity approach is shaping the...

Northern Oil and Gas (NOG) recently completed a follow on equity offering of about US$200 million, issuing 7,207,208 common shares at US$27.75. This event can influence supply, liquidity and investor sentiment. See our latest analysis for Northern Oil and Gas. The follow on offering comes as Northern Oil and Gas trades at US$27.69, with a 90 day share price return of 27.02% and a 5 year total shareholder return of 167.59%. This suggests recent momentum alongside longer term gains, despite a 1...

Wondering whether Upstart Holdings at around US$25.83 is starting to look like value or still carries more risk than reward? This article walks through the numbers to help you frame that question clearly. The stock has seen sharp swings, with returns of 6.0% decline over 7 days, 15.8% decline over 30 days, a 43.7% decline year to date, and a 49.4% decline over the last year, set against an 83.1% gain over three years and a 77.0% decline over five years. Recently, attention on Upstart has...

Royal Gold (RGLD) is drawing fresh attention after a mixed Q4 2025 earnings report, a raised annual dividend, and management’s plan to eliminate debt by early 2027 ahead of a detailed Investor Day guidance update. See our latest analysis for Royal Gold. After a sharp 15.2% 30 day share price decline and a 12.1% 7 day pullback to around $242.52 following the mixed Q4 results, Royal Gold still sits on a 9.7% year to date share price gain and a 58.2% 1 year total shareholder return. This...

If you are wondering whether On Holding's current share price properly reflects its potential, the starting point is understanding how the market is valuing the business today. The stock closed at US$39.05, with returns of a 1% decline over 7 days, a 13.8% decline over 30 days, a 16.8% decline year to date, a 17.0% decline over 1 year, and a 42.7% gain over 3 years, which hints that the market's view of its prospects and risks has shifted over time. Recent news coverage has focused on On...

Skyward Specialty Insurance Group (SKWD) has drawn attention after recent trading saw the share price around $42.83, with returns weaker over the past month and the past 3 months compared with the prior 3 years. See our latest analysis for Skyward Specialty Insurance Group. For context, the 1 day share price return of a 4.9% decline and the 90 day share price return of a 17.3% decline sit against a 3 year total shareholder return of 120.1%. This suggests that recent momentum has cooled after...

In the past week, ResMed’s share price weakness has erased about US$3.30 billion from its market value, leaving the company at roughly US$34.00 billion despite reports that its operating performance and financial condition remain solid. This disconnect between market sentiment and underlying business health raises questions about whether recent trading reflects short-term emotion rather than changes in ResMed’s long-term outlook. Against this backdrop of recent market value erosion despite...

If you are wondering whether Luckin Coffee is priced attractively today or running ahead of itself, this breakdown will help you frame what the current share price might be implying. Over the last year, the stock has returned 0.9%, after a 3.7% decline over the past week and a 6.9% decline over the past month from a last close of US$33.92. These moves may have shifted how some investors think about its potential and risk. Recent coverage around Luckin Coffee has focused on its position in...

Wondering whether Fortune Brands Innovations at around US$41.35 is starting to look like value or still has more risk priced in? This article walks through the key signals to help you frame that question. The stock has seen a 8.5% decline over the last 7 days, a 19.4% decline over the last 30 days, and is tracking 18.8% lower year to date, with a 33.6% decline over the last 12 months and longer term 24.0% and 41.0% declines over 3 and 5 years respectively. These moves have attracted...

Teamsters Local 528 workers at Keurig Dr Pepper's Norcross and Union City, Georgia, facilities have voted to authorize a strike. The authorization follows contract talks that have not produced an agreement, and the union has indicated it is prepared to strike if no improved offer emerges. The potential labor action raises operational and supply chain risks for NasdaqGS:KDP in this regional market. Keurig Dr Pepper, traded as NasdaqGS:KDP, is a major beverage company with brands spanning...